Bakgrunn og aktiviteter
Anna Mary Bofin er professor i medisin (patologi) og faglig leder av Forskerlinjen i medisin ved Fakultet for medisin og helsevitenskap, NTNU
Undervisning:
Anna Mary Bofin underviser i faget Patologi ved:
Profesjonsstudiet i medisin, Fakultet for medisin og helsevitenskap, NTNU
Forskningsprosjekter:
Subtyper av brystkreft: Molekylærpatologi og epidemiologi
http://www.ntnu.edu/ism/sub_breastcancerMedisinsk embetseksamen/Doktorgrad:
1979: Medisinsk embetseksamen, Royal College of Surgeons in Ireland, Dublin.
1982: Norsk autorisasjon som lege
1994: Spesialist i patologi.
2004: Medisinsk doktorgrad (dr med), Universitetet iTrondheim:
Fine needle aspiration cytology in the primary investigation of breast tumours and in the determination of treatment strategies.
ISBN 82-471-6243-1 (printed ver.)
ISSN 1503-3465
Publikasjoner/ foredrag:
Vitenskapelig, faglig og kunstnerisk arbeid
Et utvalg av nyere tidsskriftspublikasjoner, kunstneriske produksjoner, bok, inklusiv bokdeler og rapport-del. Se alle publikasjoner i databasen
Tidsskriftspublikasjoner
- (2019) Microvessel density in breast cancer: The impact of field area on prognostic informativeness. Journal of Clinical Pathology.
- (2018) The prognostic value of androgen receptors in breast cancer subtypes. Breast Cancer Research and Treatment.
- (2018) Nephronectin is Correlated with Poor Prognosis in Breast Cancer and Promotes Metastasis via its Integrin-Binding Motifs. Neoplasia. vol. 20 (4).
- (2018) Characterization of FGD5 expression in primary breast cancers and lymph node metastases. Journal of Histochemistry and Cytochemistry.
- (2017) Basal markers and prognosis in luminal breast cancer. Breast Cancer Research and Treatment. vol. 163 (2).
- (2017) Quantifying tumour vascularity in non-luminal breast cancers. Journal of Clinical Pathology. vol. 70 (9).
- (2017) SFRP4 gene expression is increased in aggressive prostate cancer. Scientific Reports. vol. 7.
- (2017) FGD5 amplification in breast cancer patients is associated with tumor proliferation and a poorer prognosis. Breast Cancer Research and Treatment. vol. 162 (2).
- (2016) HER2 gene copy number and breast cancer-specific survival. Histopathology. vol. 69 (5).
- (2016) Presence of TMPRSS2-ERG is associated with alterations of the metabolic profile in human prostate cancer. OncoTarget.
- (2016) A novel non-canonical Wnt signature for prostate cancer aggressiveness. OncoTarget. vol. 8 (6).
- (2016) Prevalence of human papillomavirus infection among women in rural Nepal. Acta Obstetricia et Gynecologica Scandinavica. vol. 96 (1).
- (2016) Molecular subtypes of breast cancer: Long-term incidence trends and prognostic differences. Cancer Epidemiology, Biomarkers and Prevention. vol. 25 (12).
- (2015) Alterations in collagen fibre patterns in breast cancer. A premise for tumour invasiveness?. Acta Pathologica, Microbiologica et Immunologica Scandinavica (APMIS). vol. 123 (1).
- (2015) MRI Reveals the in Vivo Cellular and Vascular Response to BEZ235 in Ovarian Cancer Xenografts with Different PI3-Kinase Pathway Activity. British Journal of Cancer. vol. 112 (3).
- (2015) Invasive lobular breast cancer: The prognostic impact of histopathological grade, E-cadherin and molecular subtypes. Histopathology. vol. 66 (3).
- (2015) Microvascular proliferation in luminal A and basal-like breast cancer subtypes. Journal of Clinical Pathology. vol. 68 (11).
- (2015) Community-based health education has positive influence on the attitude to cervical cancer screening among women in rural Nepal. Journal of Cancer Education. vol. Published ahead of print.
- (2014) Metabolic characterization of triple negative breast cancer. BMC Cancer. vol. 14.
- (2014) TOP2A gene copy number change in breast cancer. Journal of Clinical Pathology. vol. 67 (5).